Verona Pharma (VRP)

 

Latest News

Appointment of CFO

Verona Pharma plc ("Verona Pharma" or the "Company") Appointment of CFO 26 September 2016, Cardiff ? Verona Pharma plc (AIM: VRP.L), the drug development company focused on first-in-class medicines to treat respiratory diseases, announces the appointment of Piers John Morgan as Chief Financial Officer with effect from 26 September 2016. Mr Morgan...

Half-year Report

Verona Pharma plc ("Verona Pharma" or the "Company") Interim results for the six months ended 30 June 2016 Significant clinical progress and strong balance sheet bodes well for future of RPL554 13 September 2016, Cardiff ? Verona Pharma plc (AIM: VRP.L), the drug development company focused on first-in-class medicines to treat respiratory diseases, today a...

Appointment of Vikas Sinha as Non-Executive Director

Verona Pharma plc ("Verona Pharma" or the "Company") Appointment of Vikas Sinha as Non-Executive Director 12 September 2016, Cardiff ? Verona Pharma plc (AIM: VRP), a drug development company focused on first-in-class medicines to treat respiratory diseases, today announces the appointment of Vikas Sinha to the Board of Verona Pharma as a Non-Ex...

Data on RPL554 to be presented at ERS Congress

Verona Pharma plc ("Verona Pharma" or the "Company") New clinical data on RPL554 to be presented at the 2016 ERS International Congress Detailed data from Phase 2a ?add-on? trial as ?LATE-BREAKING abstract? 30 August 2016, Cardiff ? Verona Pharma plc (AIM: VRP.L), the drug development company focused on first-in-class medicines to treat respirator...

All News

DateHeadlineSource
26-09-16Appointment of CFORNS
13-09-16Half-year ReportRNS
12-09-16Appointment of Vikas Sinha as Non-Executive DirectorRNS
30-08-16Data on RPL554 to be presented at ERS CongressRNS
10-08-16Notice of ResultsRNS
09-08-16Director Deals - Verona Pharma PLC (VRP)StockMarketWire
09-08-16Director DealingRNS
05-08-16Holding(s) in CompanyRNS
04-08-16Verona Pharma grants options StockMarketWire
04-08-16Grant of Share OptionsRNS
04-08-16Holding(s) in CompanyRNS
03-08-16Holding(s) in CompanyRNS
03-08-16Holding(s) in CompanyRNS
03-08-16Holding(s) in CompanyRNS
02-08-16Holding(s) in Company - ReplacementRNS
02-08-16Holding(s) in CompanyRNS
01-08-16Holding(s) in CompanyRNS
01-08-16Holding(s) in CompanyRNS
01-08-16Holding(s) in CompanyRNS
29-07-16Admission of Placing SharesRNS
22-07-16Result of GMRNS
01-07-16Notice of GMRNS
27-06-16Verona Pharma resolutions passed at AGMStockMarketWire
27-06-16Result of AGMRNS
20-06-163 soaring small-caps: STM Group plc (+12%), Verona Pharma plc (+20%) and NAHL Group plc (+9%)Motley Fool
20-06-16Verona Pharma raises £44.7mStockMarketWire
20-06-16FTSE soars as Brexit fears easeStockMarketWire
20-06-16Verona Pharma raises gross proceeds of £44.7 million through placingStockMarketWire
20-06-16Proposed Placing and Notice of General MeetingRNS
17-06-16Proposed Placing and Notice of General MeetingRNS
03-06-162015 Annual Report and Accounts, Notice of AGMRNS
03-06-16Final ResultsRNS
27-05-16Verona Pharma schedules FY results StockMarketWire
27-05-16Notice of ResultsRNS
10-05-16Verona Pharma notes add-on Phase II RPL554 study StockMarketWire
10-05-16Add-on Phase II RPL554 studyRNS
04-05-16Verona to present RPL554 at the ATS ConferenceRNS
19-04-16Verona Pharma changes registered office StockMarketWire
19-04-16Change of Registered OfficeRNS
15-04-16Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:VRP Editorial
  • Regulatory news feed for LSE:VRP Regulatory